Tag: US2300311063

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients following a single target dose of CLN-978

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsUS2300311063

Ramaco Resources to Participate in StoneX Fourth Annual Natural Resources Summit

MNA: Brigham Nurses to Hold Strike Authorization Vote as Mass General Brigham Contract Proposals Undermine Safe Patient Care and the BWH Nursing Workforce

The Inner Circle acknowledges Dr. Susan Blyskal as a Pinnacle Professional Member Inner Circle of Excellence

Tag: US2300311063

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us